Product

Dendritic cells (DCs) are a population of professional antigen-presenting cells with an exceptionally strong capacity to activate naive T cells, and they are the initiators of the adaptive immune response. DCs exhibit remarkable plasticity: they can both drive immune activation and induce immune tolerance, and they perform multiple functions including antigen presentation, immune tolerance, T-cell polarization, B-cell regulation, and participation in innate immune responses. Owing to this plasticity, DCs have become a research focus in both basic and clinical studies of many diseases, such as transplantation, oncology, and autoimmune diseases.

Under normal conditions, DCs are present at low abundance, accounting for only about 1% of human peripheral blood mononuclear cells. To meet the needs of drug development, SailyBio provides induction services for immature and mature dendritic cells (iDC/mDC), facilitating the rapid advancement of related research.

SailyBio's dendritic cell induction service covers two specifications, immature DCs (iDC) and mature DCs (mDC). The induced products can be used in DC–T cell co-culture, MLR assays, and vaccine evaluation, supporting studies in tumor immunology, transplantation, and autoimmune diseases.